<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.3.2" -->
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>
<channel>
	<title>Comments on: Safety, Costs and Quality of Medicines</title>
	<link>http://www.healthpolcom.com/blog/2008/03/25/safety-costs-and-quality-of-medicines/</link>
	<description>A Forum for Discussing and Analyzing Healthcare Issues</description>
	<pubDate>Wed, 07 Jan 2009 00:38:47 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.3.2</generator>
		<item>
		<title>By: Health Policy and Communications Blog &#187; Blog Archive &#187; Canada&#8217;s Proposal for Subsequent Entry Biologics</title>
		<link>http://www.healthpolcom.com/blog/2008/03/25/safety-costs-and-quality-of-medicines/#comment-104</link>
		<dc:creator>Health Policy and Communications Blog &#187; Blog Archive &#187; Canada&#8217;s Proposal for Subsequent Entry Biologics</dc:creator>
		<pubDate>Tue, 01 Apr 2008 21:23:19 +0000</pubDate>
		<guid>http://www.healthpolcom.com/blog/2008/03/25/safety-costs-and-quality-of-medicines/#comment-104</guid>
		<description>[...] writing about Follow-On Biologics in a recent posting, I saw a notice about Health Canada&#8217;s proposal for how they would approve biologic products [...]</description>
		<content:encoded><![CDATA[<p>[&#8230;] writing about Follow-On Biologics in a recent posting, I saw a notice about Health Canada&#8217;s proposal for how they would approve biologic products [&#8230;]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
